Riskpilot← Back to searchSign inGet full accessBIOSYNTECH AS
ASActiveOrg 827602752Rådhusveien 15, 6570 SmølaResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
-93% vs 2023
Equity ratio
53.3%
Financial strength
Net profit 2024
NOK -136K
-91% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -137K | -93% |
| Net profit | NOK -136K | -91% |
| Total assets | NOK 70K | -69% |
| Equity | NOK 37K | -78% |
| Employees | 0 | — |
Legal name
BIOSYNTECH AS
Org number
827602752
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4. oktober 2021
Share capital
NOK 330 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Forskning, utvikling, drift og tilrettelegging av aktiviteter knyttet til utvikling av bærekraftige ingredienser for bruk i fiske- og dyrefôr, herunder å delta i andre selskap med lignende virksomhet eller på annen måte gjøre seg interessert i andre foretak.
Address
Rådhusveien 15, 6570 Smøla
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −0 | −76 | −71 | −137 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −0 | −76 | −71 | −137 |
| Net financials | 0 | 0 | 0 | 1 |
| Profit before tax | −0 | −76 | −71 | −136 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −0 | −76 | −71 | −136 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 24 | 17 | 224 | 70 |
| Equity | 20 | −56 | 173 | 37 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 4 | 73 | 51 | 33 |
| Total debt | 4 | 73 | 51 | 33 |
EBITDA margin
-13697500.0%
This company
15.8%
Market median
-86693138% vs market
20212024
Equity ratio
53.3%
This company
38.2%
Market median
+40% vs market
20212024
Return on equity
-364.8%
This company
18.4%
Market median
-2083% vs market
20212024
Net profit margin
-13582500.0%
This company
8.1%
Market median
-167685285% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-07-15 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OØ | Board of Directors | 2021 | — | — |
| Board of Directors | 2023 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bo To As | Company | 25.0% | 25.0% | 2022 |
SYNERGIFABRIKKEN AS | Company | 25.0% | 25.0% | 2022 |
Solusinet As | Company | 25.0% | 25.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bogestilla As
BIOSYNTECH AS Board members of BIOSYNTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ola Øyen | Board of Directors | 0 companies |
| Gunnar Sæthern Eskeland | Board of Directors | 0 companies |
| Øystein Selen | Chairman | 0 companies |
| Jørn Morten Einen | Board of Directors | 0 companies |
| Tom Kristian Hoffmann | Board of Directors | 0 companies |
| Dag Hjelle | Board of Directors | 0 companies |